The following July 2024 human study/randomized controlled trial (RCT) link suggests that oral caffeine at 50 mg after breakfast and 50 mg after dinner, for a total of 100 mg of caffeine per day, can improve motor symptoms as determined by UPDRS III testing :
pmc.ncbi.nlm.nih.gov/articl...
The study also determined that caffeine given over just a 3 week period showed a significant improvement in MDS UPDRS III score compared to pre caffeine testing.
The study also showed that 26% of participants experienced side effects related to the caffeine intervention, but the side effects tended to diminish over the 3 week testing. These side effects were not seen in the placebo group.
Here are some relevant quotes from the RCT :
' Approximately 80.0% of the patients receiving caffeine therapy exhibited motor improvement. Meanwhile, only 16.7% of the participants exhibited motor improvement after the treatment with a placebo. '
' Furthermore, caffeine administration at a dose of 100 mg/day would give a patient 1.5 times likelihood to experience improved motor function instead of undesirable effects (likelihood to be helped or harmed (LHH) 1.5) (Table 5). '
' This study showed a significant improvement in motor function in patients receiving caffeine adjuvant therapy. Caffeine adjuvant therapy for 21 days (2×50 mg/oral daily) was able to reduce the UPDRS III score in 80.0% of the patients in the intervention group, whereas placebo at the same dose failed to improve motor function in more than 83.3% of the patients in the control group. Additionally, patients receiving caffeine treatment had a 20 times higher chance of experiencing motor improvement as compared to those taking a placebo (Table 4). This finding was in line with that reported in a previous study, suggesting that caffeine administration 100 mg/day had reduced the occurrence of freezing of gait [12]. Another study also reported that caffeine therapy 2×100 mg/oral daily had significantly improved motor function after three weeks of treatment [10]. '
" We found that 4 out of 15 (26.6%) patients receiving caffeine therapy experienced adverse effects (i.e., heart palpitation, frequent urination, difficulty sleeping, and anxiety); however, these conditions improved over time during the intervention. A similar finding was reported in a previous study, indicating that 17.0% of the patients undergoing caffeine treatment experienced undesirable effects such as gastrointestinal disturbance, insomnia, anxiety, headache, frequent urination, nausea, and palpitation [10,27]. However, the effects of caffeine are dose-dependent and vary among individuals, in which doses of 400 are often linked to undesirable effects [28]. '
The three week testing period was relatively short in order to show benefit in UPDRS III scoring, so self testing by those who do, won't be a long drawn out process to see if similar results can be obtained and caffeine as a supplement is inexpensive as seen in the following link :
amazon.com/Caffeine-Tablets...
It is a bit challenging finding 50 mg caffeine capsules or pills as most of the the caffeine pills or capsules are 100 mg or higher. The above link is for 100 mg pills and would require also buying an inexpensive pill splitter if don't already have one. Another consideration is that many of the caffeine supplements are pre combined with other supplements such as L-Theanine which is thought to have a calming effect, but that may be a useful feature when taking caffeine which can have a stimulating effect. Here is a link to a supplement which contains 50 mg of caffeine + 100 mg of L-Theanine :
amazon.com/Caffeine-L-Thean...
L-Theanine has shown benefit in PD animal models for motor function improvement also, but to the best of my knowledge, not in humans as discussed in this new (October 2024) animal study :
sciencedirect.com/science/a....
Here are some relevant study quotes :
' l-theanine, an amino acid primarily found in tea leaves, has garnered attention for its potential neuroprotective properties. '
' l-theanine exhibits the potential to alleviate both the motor impairments and non-motor symptoms linked with Parkinson's disease (PD). '
'L-theanine shields the dopaminergic neurons from degeneration and improves the number of tyrosine hydroxylase-positive cells. '
' The principal mechanism involves reducing neuroinflammation, precisely astrogliosis, and diminishing NOS-positive neurons. '
' This study underscores the importance of nutraceuticals like l-theanine as alternative therapy in PD. '
So perhaps the combination of Caffeine and L-Theanine may be a more useful adjuvant for PD, but apparently based on the first study, caffeine alone is useful for improving motor symptom UPDRS III scoring in three weeks.
Art